Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Timmermann

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2022
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeInken Tödt, Bassam Al-Fatly, Oliver Granert, et al.
Parkinsonism & Related Disorders|September 18, 2022
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM studyDaniel Weiss, Zied Landoulsi, Patrick May, et al.
Pain|October 12, 2020
The Parkinson disease pain classification system: results from an international mechanism-based classification approachVeit Mylius, Santiago Perez Lloret, Rubens G Cury, et al.
World Neurosurgery|November 14, 2016
Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease SpecialistsWolfgang Hamel, Johannes A Köppen, François Alesch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2023
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T Jost, Marie-Ann Kaldenbach, Angelo Antonini, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's diseaseJens Volkmann, Alberto Albanese, Jaime Kulisevsky, et al.
The Lancet. Neurology|August 16, 2014
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trialJens Volkmann, Joerg Mueller, Günther Deuschl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2021
Quality of Life After Deep Brain Stimulation of Pediatric Patients with Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study with a Subsequent Randomized Double-Blind Crossover (STIM-CP)Anne Koy, Andrea A Kühn, Julius Huebl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's diseaseElena Moro, Andres M Lozano, Pierre Pollak, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2022
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeInken Tödt, Bassam Al-Fatly, Oliver Granert, et al.
Parkinsonism & Related Disorders|September 18, 2022
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM studyDaniel Weiss, Zied Landoulsi, Patrick May, et al.
Pain|October 12, 2020
The Parkinson disease pain classification system: results from an international mechanism-based classification approachVeit Mylius, Santiago Perez Lloret, Rubens G Cury, et al.
World Neurosurgery|November 14, 2016
Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease SpecialistsWolfgang Hamel, Johannes A Köppen, François Alesch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2023
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T Jost, Marie-Ann Kaldenbach, Angelo Antonini, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's diseaseJens Volkmann, Alberto Albanese, Jaime Kulisevsky, et al.
The Lancet. Neurology|August 16, 2014
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trialJens Volkmann, Joerg Mueller, Günther Deuschl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2021
Quality of Life After Deep Brain Stimulation of Pediatric Patients with Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study with a Subsequent Randomized Double-Blind Crossover (STIM-CP)Anne Koy, Andrea A Kühn, Julius Huebl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's diseaseElena Moro, Andres M Lozano, Pierre Pollak, et al.
Pageof 31